Please login to the form below

Not currently logged in
Email:
Password:

cell therapies

This page shows the latest cell therapies news and features for those working in and with pharma, biotech and healthcare.

Sangamo bulks up in cell therapy with TxCell acquisition

Sangamo bulks up in cell therapy with TxCell acquisition

s Kite unit, signed earlier this year, and it also has an early-stage programmes in stem cell therapies for blood diseases and off-the-shelf (allogeneic) CAR-Ts for cancer. ... generation autologous and allogeneic CAR-Treg cell therapies for use in

Latest news

More from news
Approximately 2 fully matching, plus 86 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    Cell and gene therapies in particular are heralding remarkable curative medicines, which are given only once, or over the short term. ... Healthcare systems are currently set up to cover moderate costs for chronic therapies over a medium to longer period

  • The good, the bad and the ugly The good, the bad and the ugly

    The oncology market is certainly evolving. “Some of the most interesting play is in immuno-oncology, where combination therapies are increasingly being explored. ... It will also be interesting to see how gene therapies and cell-based therapies, like

  • Can UK pharma rise to the post-Brexit challenge? Can UK pharma rise to the post-Brexit challenge?

    to deliver a medicine, and it is much easier to secure funding for stem cell research for developing advanced therapies in the UK compared to the US.

  • Deal Watch March 2017 Deal Watch March 2017

    Sartorius. Acquisition. Platform, instrumentation, software and reagents for real-time live cell analysis. ... Sanford Health. Strategic financing. Cell-based therapies for rotator cuff injuries and venous ulcer treatments.

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    The NICE appraisal methods and decision framework are applicable to regenerative medicines and cell therapies. ... Local funding questions remain unanswered. Questions remain as to how treatment centres are to be funded for cell therapies.

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

  • Abeona Therapeutics appoints new additions to board of directors Abeona Therapeutics appoints new additions to board of directors

    Abeona Therapeutics, a clinical stage biopharmaceutical company focused on developing cell and gene therapies, has expanded its board of directors through the appointment of Stefano Buono and Richard Van Duyne. ... He said: “Abeona’s ambitious gene

  • Turnstone Biologics bolsters leadership team Turnstone Biologics bolsters leadership team

    Prior to his new role, he was chief business officer at SQZ Biotech, a clinical-stage group focusing on developing cell therapies.

  • Avita Medical appoints CEO Avita Medical appoints CEO

    chief scientific officer, global business development and licensing, and chief scientific officer for its cell and gene therapy unit. ... Prior to Novartis Perry was global head of R&D for the bioscience division at Baxter Healthcare, vice president of

  • apceth Biopharma appoints Dusan Kosijer as CFO apceth Biopharma appoints Dusan Kosijer as CFO

    In parallel, apceth’s pipeline has recently entered a very thrilling phase, encouraging us to accelerate further the development of our first-in-class, first-in-man cell-based gene therapies.”. ... Moreover, Dusan’s experience will strongly promote

  • Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

    At Cambridge, US-based Neon he will be tasked with guiding the immuno-oncology company's research programmes, which are focused on developing neoantigen-based therapeutic vaccines and T cell therapies.

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics